Disclosed positions
| STATE STR SPDR S&P 500 ETF T | SPY | TR UNIT | $2,389,664,000 | 3,200,000 | SH | Put |
| ISHARES TR | IWM | RUSSELL 2000 ETF | $1,742,610,000 | 5,800,000 | SH | Put |
| MADRIGAL PHARMACEUTICALS INC | MDGL | COM | $154,641,600 | 288,000 | SH | None |
| CYTOKINETICS INC | CYTK | COM NEW | $130,340,700 | 1,530,000 | SH | Call |
| SUPERNUS PHARMACEUTICALS | SUPN | COM | $123,074,809 | 2,646,201 | SH | None |
| AGIOS PHARMACEUTICALS INC | AGIO | COM | $104,279,100 | 2,810,000 | SH | Call |
| CYTOKINETICS INC | CYTK | COM NEW | $102,342,325 | 1,201,342 | SH | None |
| INCYTE CORP | INCY | COM | $102,024,567 | 900,005 | SH | None |
| NEUROCRINE BIOSCIENCES INC | NBIX | COM | $90,307,457 | 535,838 | SH | None |
| TRAVERE THERAPEUTICS INC | TVTX | COM | $89,335,941 | 1,572,539 | SH | None |
| AGIOS PHARMACEUTICALS INC | AGIO | COM | $89,064,000 | 2,400,000 | SH | None |
| PTC THERAPEUTICS INC | PTCT | COM | $87,393,690 | 1,071,395 | SH | None |
| UNITEDHEALTH GROUP INC | UNH | COM | $76,060,290 | 183,000 | SH | None |
| FRESHPET INC | FRPT | COM | $74,532,702 | 1,260,702 | SH | None |
| DYNE THERAPEUTICS INC | DYN | COM | $68,567,289 | 3,087,226 | SH | None |
| AMAZON COM INC | AMZN | COM | $67,822,507 | 284,562 | SH | None |
| IMMUNOVANT INC | IMVT | COM | $66,888,080 | 1,736,000 | SH | None |
| RIGEL PHARMACEUTICALS INC | RIGL | COM | $65,408,640 | 1,672,000 | SH | None |
| THERMO FISHER SCIENTIFIC INC | TMO | COM | $61,406,573 | 122,480 | SH | None |
| IRONWOOD PHARMACEUTICALS INC | IRWD | COM CL A | $58,653,720 | 13,932,000 | SH | None |
| HARMONY BIOSCIENCES HLDGS IN | HRMY | COM | $56,945,240 | 1,564,000 | SH | None |
| REGENERON PHARMACEUTICALS | REGN | COM | $55,999,504 | 89,809 | SH | None |
| PTC THERAPEUTICS INC | PTCT | COM | $53,836,200 | 660,000 | SH | Call |
| NEKTAR THERAPEUTICS | NKTR | COM NEW | $50,542,440 | 724,000 | SH | None |
| MINERALYS THERAPEUTICS INC | MLYS | COM | $46,837,280 | 1,736,000 | SH | None |
| IMMUNOVANT INC | IMVT | COM | $46,236,000 | 1,200,000 | SH | Call |
| SANOFI SA | SNY | SPONSORED ADR | $45,390,240 | 1,064,000 | SH | None |
| IMMUNOCORE HLDGS PLC | IMCR | ADS | $45,339,000 | 1,428,000 | SH | None |
| ALPHABET INC | GOOGL | CAP STK CL A | $45,205,161 | 126,494 | SH | None |
| SOLID BIOSCIENCES INC | SLDB | COM NEW | $42,737,220 | 4,278,000 | SH | None |
| MONGODB INC | MDB | CL A | $42,045,275 | 125,172 | SH | None |
| KURA ONCOLOGY INC | KURA | COM | $40,347,660 | 3,678,000 | SH | None |
| DENTSPLY SIRONA INC | XRAY | COM | $38,959,920 | 3,672,000 | SH | None |
| UBER TECHNOLOGIES INC | UBER | COM | $35,929,041 | 497,908 | SH | None |
| AXOGEN INC | AXGN | COM | $35,797,250 | 775,000 | SH | None |
| DISC MEDICINE INC | IRON | COM | $33,644,400 | 460,000 | SH | None |
| GITLAB INC | GTLB | CLASS A COM | $32,793,525 | 1,074,141 | SH | None |
| FIVE9 INC | FIVN | COM | $32,747,520 | 1,536,000 | SH | None |
| HUBSPOT INC | HUBS | COM | $32,495,358 | 178,047 | SH | None |
| ALIGN TECHNOLOGY INC | ALGN | COM | $30,407,037 | 180,286 | SH | None |
| MICROSOFT CORP | MSFT | COM | $30,058,325 | 80,581 | SH | None |
| ORTHOFIX MED INC | OFIX | COM | $29,832,960 | 3,264,000 | SH | None |
| HUMANA INC | HUM | COM | $28,809,175 | 72,527 | SH | None |
| ANGIODYNAMICS INC | ANGO | COM | $28,595,980 | 2,198,000 | SH | None |
| TRAVERE THERAPEUTICS INC | TVTX | COM | $28,405,000 | 500,000 | SH | Call |
| WATERS CORP | WAT | COM | $28,129,500 | 75,004 | SH | None |
| MINERALYS THERAPEUTICS INC | MLYS | COM | $28,059,200 | 1,040,000 | SH | Call |
| SENTINELONE INC | S | CL A | $27,152,000 | 1,600,000 | SH | Call |
| VERASTEM INC | VSTM | COM NEW | $26,831,680 | 7,024,000 | SH | None |
| 4D MOLECULAR THERAPEUTICS IN | FDMT | COM | $26,600,000 | 2,000,000 | SH | None |
No matching rows. Clear the filter to see all records.
Largest 50 positions by reported value; the filing may contain more positions.
How amendments affect these holdings
This view uses 1 effective filing version(s). A restatement replaces the previous book; a new-holdings amendment adds positions. 10 positions lack a resolved ticker and 10 positions are put or call entries.
A 13F is a delayed quarterly snapshot of disclosed holdings. It is not a complete trade ledger and does not reveal every position in a manager's portfolio. Option values refer to the reported underlying position rather than a traded option premium.
Quarter end and public filing date
Use the filing's public availability date when constructing a historical observation. The quarter-end report period is earlier and cannot be substituted for when the public learned the holdings.